Stephanie L Aungst (Stephanie Aungst)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Locally Advanced

Small Cell Lung Cancer

Tyrosine Kinase

Myasthenia Gravis

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for locally advanced or metastatic ROS1-positive non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Katie Chon, Erin Larkins, Somak Chatterjee, Pallavi S Mishra-Kalyani, Stephanie L Aungst, Emily Wearne, Sriram Subramaniam, Yangbing Li, Jiang Liu, Jielin Sun, Rosane Charlab, Hong Zhao, Banu Saritas-Yildirim, Rama Kamesh Bikkavilli, Soma Ghosh, Reena Philip, Julia A Beaver, Harpreet Singh
FDA Approval Summary: Amivantamab for the Treatment of patients with non-small cell lung cancer with EGFR exon 20 insertion mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)